Earnings

Total revenue increased by $6.8 million, or 12%, to $63.9 million.Cybersecurityrevenue rose about 11% to $44.9 million, while Digital Agreements revenue rose 14% to $19.0 million, helped by overage usage fees, customer expansions and new logos.

Net revenues were $403.5 million, up $18.9 million, or 4.9%, from $384.6 million. Security, the largest division, grew 3.9% to $264.1 million, with product revenues up about $3.6 million and service revenues up about $6.2 million. The company cited higher RF system and checkpoint …

For the nine months ended September 30, 2026, diluted EPS was $2.32, up 19.6% from $1.94. Return on averageAssetswas 1.38%, against 1.35% a year ago, while return on average shareholders'Equitywas 12.03% versus 11.92%.

Total revenues rose by $4.0 million to $402.7 million from $398.7 million. On a calculated basis, that is growth of about 1.0%, achieved despite a $23.1 million decline in revenues from non-comparable properties that were sold.

Compared with the second quarter, net income rose 32% from $22 million, while revenues slipped 6% from $497 million. AnnualizedReturn on Equitywas 3%, versus 2% in the prior quarter and 18% a year earlier.

Net investment income fell to $36 million from $73 million in the prior quarter and $99 million a year earlier. Adjusted net income, a non-GAAP measure, was $30 million, or $0.35 per share, which the company said equals an annualized adjustedReturn on Equityof 9%. …

Revenue was $410.1 million, up $55.5 million from $354.7 million a year earlier. Thrombectomy revenue rose 18.1% to $279.2 million, which the company attributed mainly to higher U.S.Volumefrom new products and further penetration of existing ones. Embolization and access revenue rose 10.8% to $131.0 …